News

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
Could weight loss drugs help prevent cancer? Here's what a new study found.
Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.
Provinces should cover weight-loss drugs for people with pre-existing cardiovascular disease, says drug agency
Report from Canada’s Drug Agency says Wegovy cuts risk of heart attack, stroke or cardiovascular death by 20 per cent ...
InsideNoVa4h
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...
WGAL on MSN17h
Counterfeit market growing for weight-loss drugs
Inadequate supply has created opportunities for bad actors seeking to profit from shortages, high costs and demand ...
pharmaphorum16h
Zepbound tops Wegovy in first head-to-head weight-loss trial
The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide ... 25% body weight loss compared to ...
pharmaphorum16h
Novo Nordisk leaps on new obesity drug data
The results are a boost to Novo Nordisk after another weight-loss therapy ... with semaglutide-based products Ozempic for type 2 diabetes and Wegovy for obesity, but is coming under competitive ...